Abattis Bioceuticals Corp.
ATTBF
Market Cap$47.78K
Close$
Share Statistics
| Market cap | $47,780.00 |
|---|---|
| Enterprise Value | $-402,059.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.01 |
| Beta | -46.51 |
| Outstanding Shares | 477,884,481 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.02 |
|---|---|
| PEG | 0.02 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -1.13 |
| Enterprise Value to EBIT | 0.1 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -3.9 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Abattis Bioceuticals Corp.
CEO: Robert Abenante Abattis Bioceuticals Corp. engages in the aggregation, integration, and investment in agricultural technologies and biotechnology services for the legal cannabis industry developing in Canada. It produces, markets, and licenses proprieta...